Minot DeBlois Advisors LLC

Position in NVS — Novartis AG

CIK 1475933 Boston, MA

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,111,301

-$42,878 QoQ

Shares Held

7,091

-6.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.44%

of 13F equity value

Holder Rank

#590

of 1,603 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Minot DeBlois Advisors LLC holds $3,217,288 across 7 Drug Manufacturers - General names. NVS ranks #2 (34.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	5,371	$1,364,072
2	NVS	Novartis AG This page	7,091	$1,111,301
3	PFE	Pfizer Inc	27,487	$661,886
4	MRK	Merck & Co., Inc.	323	$41,505
5	GSK	GSK plc	600	$31,452
6	AZN	Astrazeneca PLC	37	$7,015
7	BMY	Bristol Myers Squibb Co	1	$57

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,111,301	7,091	-6.2%	Shares	Sole	2026-08-13
2026-03-31	$1,154,179	7,556	-5.1%	Shares	Sole	2026-05-08
2025-12-31	$1,098,134	7,965	-4.8%	Shares	Sole	2026-02-13
2025-09-30	$1,072,471	8,363	-6.1%	Shares	Sole	2025-11-13
2025-06-30	$1,077,594	8,905	-10.1%	Shares	Sole	2025-08-12
2025-03-31	$1,103,652	9,900	-2.8%	Shares	Sole	2025-05-15
2024-12-31	$991,102	10,185	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.